TickerLeague

EBITDA for Zoetis (ZTS)

According to Zoetis's latest reported financial statements, the company's current EBITDA (TTM) is $4.09B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

TTM (last 4 quarters)

$4.09B

YoY change

+5.1%

5Y CAGR

+8.7%

Peak year (2025)

$4.07B

Cumulative EBITDA

$34.08B

EBITDA history chart for Zoetis (ZTS) from 2009 to 2025

EBITDA history table for Zoetis (ZTS) from 2009 to 2025

Fiscal yearPeriod endedReportedEBITDAYoY
2025$4.07B+5.1%
2024$3.87B+5.1%
2023$3.69B+9.7%
2022$3.36B+5.9%
2021$3.17B+18.1%
2020$2.69B+9.4%
2019$2.46B+11.1%
2018$2.21B+13.8%
2017$1.94B+18.8%
2016$1.63B+88.2%
2015$868.00M-23.9%
2014$1.14B+13.0%
2013$1.01B+7.3%
2012$941.00M+48.2%
2011$635.00M+58.8%
2010$400.00M+19900.0%
2009$2.00M

EBITDA values are taken from Zoetis's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

Zoetis (ZTS) most recent annual EBITDA stands at $4.07B (2025) – grew 5.1% year-over-year.

Looking at the 2020–2025 (5 years) stretch, Zoetis EBITDA compounded at +8.7% per year, sustaining 10 straight years of year-over-year growth.

Across the available history, EBITDA reached its high of $4.07B in 2025 and its low of $2.00M in 2009.

Within Healthcare, Zoetis (ZTS) ranks 9th among 8 peers we track. The peer median for EBITDA is $24.21B.

Zoetis EBITDA by Year

Zoetis EBITDA 2025: $4.07B

Zoetis EBITDA in 2025 was $4.07B, grew 5.1% from 2024. This figure represents the highest annual value in the available history.

Zoetis EBITDA 2024: $3.87B

Zoetis EBITDA in 2024 was $3.87B, grew 5.1% from 2023.

Zoetis EBITDA 2023: $3.69B

Zoetis EBITDA in 2023 was $3.69B, grew 9.7% from 2022.

Zoetis EBITDA 2022: $3.36B

Zoetis EBITDA in 2022 was $3.36B, grew 5.9% from 2021.

Zoetis EBITDA 2021: $3.17B

Zoetis EBITDA in 2021 was $3.17B.

See more financial history for Zoetis (ZTS).

Sector peers — EBITDA

Companies in the same sector as Zoetis, ranked by their latest EBITDA.

CompanyEBITDASector
Novo Nordisk A/S (NVO)$156.73BHealthcare
Johnson & Johnson (JNJ)$41.05BHealthcare
Eli Lilly and Company (LLY)$27.94BHealthcare
Merck & Co., Inc. (MRK)$25.36BHealthcare
UnitedHealth Group Incorporated (UNH)$23.06BHealthcare
AstraZeneca PLC (AZN)$19.83BHealthcare
AbbVie Inc. (ABBV)$17.63BHealthcare
Amgen Inc. (AMGN)$15.84BHealthcare

Frequently asked questions

What is Zoetis's EBITDA?

Latest reported EBITDA for Zoetis (ZTS) is $4.09B (period ending December 31, 2025).

How has Zoetis EBITDA changed year-over-year?

Zoetis (ZTS) EBITDA changed +5.1% year-over-year on the latest annual filing.

What is the long-term growth rate of Zoetis EBITDA?

Zoetis (ZTS) EBITDA compound annual growth rate is +8.7% over the most recent 5 years available.

When did Zoetis EBITDA hit its highest annual value?

Zoetis EBITDA reached its highest annual value of $4.07B in 2025.

What was Zoetis EBITDA in 2024?

Zoetis (ZTS) EBITDA in 2024 was $3.87B.

What was Zoetis EBITDA in 2025?

Zoetis (ZTS) EBITDA in 2025 was $4.07B.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.